AMG 108

DRUG3 trials

Sponsors

Amgen

Conditions

Diabetes MellitusRheumatoid Arthritis

Phase 2

A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

CompletedNCT00293826

AmgenRheumatoid Arthritis

Start: 2006-03-31End: 2008-02-29Updated: 2010-03-05

Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

CompletedNCT00369473

AmgenRheumatoid Arthritis

Start: 2006-09-30End: 2008-06-30Updated: 2016-12-13

A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

WithdrawnNCT00661921

AmgenDiabetes Mellitus

Start: 2008-06-30End: 2009-10-31Updated: 2018-09-06

Related Papers

A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis.

2010-10-1517 citations